Rare Variants in TP53 and Susceptibility to Neuroblastoma

TP53 is the most frequently mutated gene in human malignancies; however, de novo somatic mutations in childhood embryonal cancers such as neuroblastoma are rare. We report on the analysis of three independent case–control cohorts comprising 10 290 individuals and demonstrate that rs78378222 and rs35850753, rare germline variants in linkage disequilibrium that map to the 3 ´ untranslated region (UTR) of TP53 and 5 ´ UTR of the Δ133 isoform of TP53, respectively, are robustly associated with neuro-blastoma (rs35850753: odds ratio [OR] = 2.7, 95 % confidence interval [CI] = 2.0 to 3.6, Pcombined = 3.43 × 10−12; rs78378222: OR = 2.3, 95 % CI = 1.8 to 2.9, Pcombined = 2.03 × 10−11). All statistical tests were two-sided. These findings add neuroblastoma to the com-plex repertoire of human cancers influenced by the rs78378222 hypomorphic allele, which impairs proper termination and polyadenylation of TP53 transcripts. Future studies using whole-genome sequencing data are likely to reveal additional rare vari-ants with large effect sizes contributing to neuroblastoma tumorigenesis. JNCI J Natl Cancer Inst (2014) 106(4): dju047 Neuroblastoma is a cancer of the devel